Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Hämmerle

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|March 27, 2013
MALAT1 -- a paradigm for long noncoding RNA function in cancerTony Gutschner, Monika Hämmerle, Sven Diederichs
Cancer Reports (Hoboken, N.J.)|February 23, 2024
Periostin is associated with prognosis and immune cell infiltration in pancreatic adenocarcinoma based on integrated bioinformatics analysisYijun Chen, Fengyu Zhang, Bolin Zhang, et al.
Cells|August 26, 2022
Single Cell Analysis of Cultivated Fibroblasts from Chronic Pancreatitis and Pancreatic Cancer PatientsYoshiaki Sunami, Yijun Chen, Bogusz Trojanowicz, et al.
RNA Biology|August 4, 2012
Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and developmentMoritz Eißmann, Tony Gutschner, Monika Hämmerle, et al.
Molecular Cancer|May 28, 2023
IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expressionSven Hagemann, Danny Misiak, Jessica L Bell, et al.
Hepatology (Baltimore, Md.)|June 4, 2013
Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1)Monika Hämmerle, Tony Gutschner, Hannah Uckelmann, et al.
Cancer Research|December 18, 2012
The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cellsTony Gutschner, Monika Hämmerle, Moritz Eissmann, et al.
Iscience|May 31, 2023
Gender-specific changes of the gut microbiome correlate with tumor development in murine models of pancreatic cancerTom Kaune, Heidi Griesmann, Katharina Theuerkorn, et al.
Hepatology (Baltimore, Md.)|January 8, 2014
Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinomaTony Gutschner, Monika Hämmerle, Nikolaos Pazaitis, et al.
Hepatology (Baltimore, Md.)|October 12, 2013
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patientsLuca Quagliata, Matthias S Matter, Salvatore Piscuoglio, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Molecular Medicine (Berlin, Germany)|March 27, 2013
MALAT1 -- a paradigm for long noncoding RNA function in cancerTony Gutschner, Monika Hämmerle, Sven Diederichs
Cancer Reports (Hoboken, N.J.)|February 23, 2024
Periostin is associated with prognosis and immune cell infiltration in pancreatic adenocarcinoma based on integrated bioinformatics analysisYijun Chen, Fengyu Zhang, Bolin Zhang, et al.
Cells|August 26, 2022
Single Cell Analysis of Cultivated Fibroblasts from Chronic Pancreatitis and Pancreatic Cancer PatientsYoshiaki Sunami, Yijun Chen, Bogusz Trojanowicz, et al.
RNA Biology|August 4, 2012
Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and developmentMoritz Eißmann, Tony Gutschner, Monika Hämmerle, et al.
Molecular Cancer|May 28, 2023
IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expressionSven Hagemann, Danny Misiak, Jessica L Bell, et al.
Hepatology (Baltimore, Md.)|June 4, 2013
Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1)Monika Hämmerle, Tony Gutschner, Hannah Uckelmann, et al.
Cancer Research|December 18, 2012
The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cellsTony Gutschner, Monika Hämmerle, Moritz Eissmann, et al.
Iscience|May 31, 2023
Gender-specific changes of the gut microbiome correlate with tumor development in murine models of pancreatic cancerTom Kaune, Heidi Griesmann, Katharina Theuerkorn, et al.
Hepatology (Baltimore, Md.)|January 8, 2014
Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinomaTony Gutschner, Monika Hämmerle, Nikolaos Pazaitis, et al.
Hepatology (Baltimore, Md.)|October 12, 2013
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patientsLuca Quagliata, Matthias S Matter, Salvatore Piscuoglio, et al.
Pageof 2